chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was given her HPV and then went to the bathroom to give a urine. When in the bathroom a thud was heard by a co-worker. I knocked on the door and asked the patient if she was okay? The patient responded , yes. I then went to the lab to grab a pregnancy test. When I returned my co-worker said you may want to check on the patient, she stated that she was not feeling well. The patient was in room 204 with the trash can. Her skin color was pale, she had dry heaved, and her skin was cool and clammy. I took the patient's blood pressure which was 94/52. I gave her a cool wash cloth to put on the back of her neck and gave her some apple juice and peanut butter crackers. We were then able to transfer her to the bed where she laid down and put her feet up. We moved the wash cloth to her forehead. Dr. was notified. While Dr. was in the room I ran the pregnancy test. When I went back in to give results I heard the patient tell Dr. that she fell in the bathroom and hit her head. She has a nickel size lump on the right side of her head. I had the patient lay there for another 15 minutes until her color returned, her skin was no longer clammy and she stated she felt okay. She had eaten 3 crackers and drank a quater of her juice. She was given 400 mg of ibuprofen for complaints of a headache. Advised her to call with any visual disturbances, continued headache, or any change in her mental status.
8 hours past second dose: fever of 103, migraines and chills for 2 days.  About 24 hours post injection : diarrhea and nausea. 14 days I could not tolerate much food.  Since the vaccine ( 6 months now) watering eyes, nasal congestion intermittent fevers. Also migraines regularly, almost every day. Last check up one week ago bounding heart, rate of 150, irregular beat, PVCs on EKG.  I feel chest pains at work intermittent however I work in ER and ICU so I can't stop to address them My PCP wants me to do more.testing. I cannot afford it.  Before this vaccine I was a healthy young woman. Now I struggle to make it theu days. I'll never do this again
pt recv vax & exp a flare up of uveitis (assoc w/herpes simplex);no other info was known as of reporting date
High pitched screaming for 3 days (more than 3 hrs over the course of 3 days), chest congestion, and low grade fever - developmentally delayed. 4/28/08-records received-evaluation 3/31/08 13 months of age- Assessment: not eligible for early intervention services.  Per family patient screamed after 2, 4 and 6 month immunizations and experienced convulsions.  Follow-up: Diagnosed w/ Autism. Suffering from seizures. Thank you for your hand in poisoning my child.
Left arm pain status post Tdap administration. Numbness patient states "feels dead" feels weaker. Pt referred to neurologist and physical therapy pending appointments.
Left thigh, red and hot to touch, approx15 minutes after vaccine administration. The doctor examined thigh, ordered an ice packed and requested that mother return to doctor's office tomorrow for F/U.
Possible vaccine failure. Onset 12/9/03. Pt has pneumonia and sepsis. Hospitalized since 12/15/03. Pt on dialysis and ventilator. Will be hospitalized indefinitely. I have been calling hospital for weekly updates. Follow up on 2/3/03 per phone report: Call from CDC Strep lab. The serotype for this child's specimen was 19A, which is not covered by Prevnar.  The medical records received on 2/4/04 state septic shock, adult respiratory distress syndrome, hemolytic uremic syndrome, pulmonary edema, and respiratory failure.  60-day follow up on 04/19/04: "Pt has recovered from adverse events.  Hospitalized for 45 days, subtype 19A (not in PCV-7)."
Patient received Moderna vaccine in error due to age under 18.  (guardian) reported no adverse events related to vaccine.
pt recv vax;exp HA,fever of 101-103 & severe stomach pain;blood work nl;1 wk later MD felt exp was hepatic & complicated by pneumonia;15aug95 exp syncope episode and nearly drowned in swimming pool;rx w/ Atenolol;
Information has been received from a physician concerning a patient who on an unspecified date was vaccinated with a 0.65mL dose of ZOSTAVAX (Oka/Merck).  The physician reported that one month after vaccination the patient developed shingles.  The outcome of the patient was unknown.  The patient sought unspecified medical attention.  Additional information has been requested. This is in follow-up to report (s) previously submitted on 3/27/2009.  Information has been received from a physician concerning a patient who on an unspecified date was vaccinated with a 0.65mL dose of ZOSTAVAX (Merck).  The physician reported that one month after vaccination the patient developed shingles.  The patient sought unspecified medical attention.  Follow up information has been received from the physician.  She reported that she was not the patient's primary healthcare provider.  The physician stated that the patient had the ZOSTAVAX (Merck) a while back and had an outbreak "long after" getting the vaccination.  She stated that she did not have much of the information requested.  Additional information is not expected.
The week of 4/28, I was emotional, foggier. I eventually had a panic attack that was so bad I thought I was having a heart attack. While getting into the ambulance, I do not know if I was hallucinating but reality was very disconnected for me, I was put on Dextroamphetamine until around June. I went to facility on 5/5. I was transferred on 5/7 to a place. I stayed here until 5/15. I am not certain if the dates are accurate because I have still not remembered those days clearly.
I tested positive for Covid-19 on December 26, 2022 my symptoms were sore throat, headaches, congestion, I was prescribed Paxlovid for my symptoms.
Prominent swelling of upper left arm at site of infection. No further care except Motrin. Local care.
Developed high fever (103F) one month after MMR. MMR given 7/16/98. Developed fever and seen in urgent care without fever and ??. 8/22/98 - dx'd with autism several months later
Sore arm; difficult sleep; GI Symptoms; fever; body aches; This is a spontaneous report from a contactable Physician. A patient of unspecified age and gender received COVID-19 vaccine (UNSPECIFIED TRADE NAME), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient experienced sore arm, difficult sleep, GI symptoms, fever and body aches on an unspecified date with outcome of unknown. Events took place after use of product.   No follow-up attempts are possible; information about batch/lot number cannot be obtained.
Pt onset 9/5 and symptoms progressed . On 9/12 Pt was having difficulty breathing and having heart issues so 911 was called and EMS Transported PT from home address to  Hospital and she has been in the hospital since. Pt has AFIB and has history of valve issues. Pt is fully vx and received Dose 2 on 4/26.
Guillain Barre. Admitted to hospital, IVIG given, discharged home, 16 Nov - 22 Nov 10.
Erythematous, slightly warm, and tender area at site of MCV injection on right posterior upper arm. Measuring 3.5 cm in diameter.
On 02-21-2021 I experienced itchiness on my skin and had a rash and I also got hives on my legs. I had a little bit of throat scratchiness but no anaphylactic. I went to see my PCP on 02-23-2021 and was prescribed antihistamine. I also saw an allergist doctor who gave me stronger medication which helped my symptoms cleared up. My symptoms lasted 5 days only.
This case was reported by a pharmacist via call center representative and described the occurrence of flu like symptoms in a 58-year-old male patient who received SHINGRIX (batch number TP5E5, expiry date 15th November 2020) for prophylaxis. Concurrent medical conditions included spine issues. On 14th June 2018 15:30, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 14th June 2018, several hours after receiving SHINGRIX, the patient experienced flu like symptoms, exhaustion, sleeplessness, general body pain and restless. On an unknown date, the outcome of the flu like symptoms, exhaustion, sleeplessness, general body pain and restless were not recovered/not resolved. It was unknown if the reporter considered the flu like symptoms, exhaustion, sleeplessness, general body pain and restless to be related to SHINGRIX. Additional details were provided as follows: The pharmacist reported that she gave a SHINGRIX shot yesterday afternoon. The patient called back this morning reporting last evening he experienced flu like symptoms with body aches, unable to sleep, restless and exhausted. The reporter reviewed the prescribing information and saw similar events reported. The reviewed duration of time of solicited local and general events and grade 3 events worse with dose 2. The referred her to have patient report to physician and for medical treatment if required.
Vaccine was stored in refrigerator on 08-Jul-2022 and administered vaccine on 09-Aug-2022; No Adverse event; Patient was administered with Moderna COVID-19 Vaccine after 30-day use by date; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered with Moderna COVID-19 Vaccine after 30-day use by date), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 08-Jul-2022 and administered vaccine on 09-Aug-2022) and NO ADVERSE EVENT (No Adverse event) in a 4-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1414B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 09-Aug-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 09-Aug-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered with Moderna COVID-19 Vaccine after 30-day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 08-Jul-2022 and administered vaccine on 09-Aug-2022) and NO ADVERSE EVENT (No Adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered with Moderna COVID-19 Vaccine after 30-day use by date), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 08-Jul-2022 and administered vaccine on 09-Aug-2022) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient was administered with Moderna COVID-19 Vaccine after 30-day use by date) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 08-Jul-2022 and administered vaccine on 09-Aug-2022).    No concomitant product use was reported.  On 08-Jul-2022, the vials were initially stored in the refrigerator.  Vial did not undergo any temperature excursions.  The healthcare professional was not aware of any symptoms for any patient after the vaccine was given.  No treatment information was provided.
Sore, swollen, red and warm to the touch. Patient took TYLENOL and BENADRYL.
Warm to touch at Left Deltoid Red, Swollen with no complaints of pain. Treatment=Benadryl.
No adverse effects reported.; administered MMR II via intramuscular route on 9/17/2019; This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. No information regarding patient's concurrent conditions, past medical history, concomitant medications, drug reactions or allergies was provided. On 17-SEP-2019, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, intramuscular for prophylaxis, lot # R030810, expiration date 24-OCT-2020 (exact dose was not provided) reconstituted with sterile diluent lot number S002638, expiration date 31-OCT-2021. The patient experienced incorrect route of product administration as intramuscular is not approved route of administration of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II). No adverse event was reported.
Hospitalized for Crohns disease on biological agent, incidentally positive for COVID without respiratory symptoms.
This spontaneous report was received from a medical assistant referring to a multiple patients of unknown age and gender. These patients' concomitant medication, pertinent medical history and drug reactions were not reported. On unspecified dates since 21-JUL-2017, these patients were administered improperly stored PNEUMOVAX 23 (lot# N014188 with expiration date 22-JAN-2019, dose and route not reported) for prophylaxis. The vaccine was exposed to temperature excursion of 47 to 77 Fahrenheit (F) for 43 minutes. There was no previous temperature excursion. The data logger was involved. No adverse effect was reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA004623: US-009507513-1709USA004621: US-009507513-1709USA004622: US-009507513-1709USA004619: US-009507513-1708USA007735.
headache - not bad enough to need pain medication with my activity set for that day, but with a different activity set I would have taken an OTC pain reliever - headache lasted throughout the first evening and got worse the next day.  After about 36 hours it had resolved itself. strange feeling that I can best describe as "trippy" - lasted from about two hours after the vaccine until I went to bed that night - The cheese I ate with dinner tasted abnormally strong, I kept feeling like everything around me was moving even though it wasn't (felt like the floor / walls were moving - similar to when I'm super tired and / or severely jet lagged), and somehow colors seemed a little off.  When I woke up the next morning this "trippy" feeling was gone.
Patient received ZOSTAVAX at 6:04pm on Friday 6-27-14. Since that time she has experienced a rash of about 6 inch in length. She states that a hard nodule is present at injection site. On occasion rash is itchy. I suggested using ice packs and BENADRYL/CLARITIN. If symptoms persist follow up with her physician.
Purpura Rash began 10/18/08 progressed to buttocks through the week; mild discomfort to knees, legs. Ultimately, diagnosed with Henoch-Schonlein Purpura. 12/9/09 Medical records received for date 10/24/08 to 11/17/08. DX: 10/24/08 purpuric rash suspect HSP. Parents c/o pt w/ rash on legs up to buttocks x1wk, fever. Parents state flumist x8days ago. Assessment: mild throat erythema, purpura. F/u appt 10/28/08 showing improvement. OV 10/29/08 DX: viral illness. Presented w/ fever, sore throat, cough. 11/5/08 f/u rash HSP. DX: HSP, UTI. Presented w/ new crop of rash on leg/knee, knee pain, stomach pain. Assessment: throat erythema, purpura rash. UA(+) protein, leukocytes. OV11/17/08 f/u appt for purpura. Assessment: WNL, no purpura, HSP resolving.
Patient experienced hives/rash within first half-hour of receiving the vaccine. She took Benadryl and rash subsided. Pt woke up the next day (4/4/21) feeling ill with heart racing, hypertension, and headache. She was scheduled to have an infusion appointment 4/5/21, which was canceled when she was found to have elevated liver enzymes and very high blood pressure. Patient went to ED on 4/6/21 for high blood pressure, lightheadedness, and headache.
Patient came into clinic 9/3/08 wit a rash on jaw/neck; diagnosed as shingles. Has had only 1 VARIVAX 12/10/04. No previous history of chickenpox.
Starting April 6 around 6 pm, ran fever of 99 to 100. My normal temp runs around 97 to 97.5. Fever, then chills, then fever again and mild body aches. By 10 pm I had no chills, but the fever remained. I also had a very intense headache. I woke up around 3 am on April 7 and no longer had fever or chills, but the headache remained and then the mild body aches started. By 2 pm April 7 I still have mild body aches. I have swollen lymph nodes under my left arm. I have mild fatigue.
A non-serious spontaneous of tested positive for influenza A manifested with fever of 103F has been received from a registered nurse concerning a seven-year-old male, subsequent to H1N1, Intranasal. The patient's medical history included runny nose which started on unknown date in Jan-2010 and was ongoing after the vaccination on 15-Jan-2010. He also had no history of asthma. No concomitant medications have been reported for this patient. The patient received H1N1, Intranasal on 15-Jan-2010 for an unknown indication. On 18-Jan-2010, the patient experienced fever of 103F and on same day tested positive for influenza A. The outcome of the event was unknown at the time of report.
Pt given FLUVIRIN and PNEUMOVAX on same date. Reported redness and swelling at injection and 100.3 temp lasting about 24 hours.
Severe pain in lymph nodes under left arm for 3-4 hours after vaccine Fever for 36 hours after vaccine Chills to date Red raised warm rash on chest a week later  Rash itchy and spread to back, neck, hips, legs and arms despite antihistamines (benadryl, zyrtec)
pt recvd vax & the next day exp a rash which spread throughout body & a raised rash; also exp itching; exp swelling in the oral area; MD felt rash was not due to vax but to evergreen;
This case was reported in a literature article and described the occurrence of Guillain Barre Syndrome in a child subject of unspecified gender who was vaccinated with Oral polio vaccine, manufacturer unspecified and DTPa. The present retrospective cohort study flaccid paralysis  was conducting using computerized diagnosis data and medical record review of potential cases among children aged 1 month to less than 15 year and diagnosed from 1 January 1992 through 31 December 1998. The subject were hospitalized or seen in the emergency room. None of the children were known to have a preexisting immunocompromising condition. The article included the description of 16 children with vaccine exposure prior to development of paralytic syndrome (B0642827A, B0642828A, B0642829A, B0642811A, B0642830A, B0642836A, B0642841A, B0642832A, B0642846A, B0642847A, B0642848A, B0642850A,B0642851A, B0642852A, B0642853A. On an unspecified date the subject received unspecified dose of DTPa and unspecified dose of Oral polio vaccine. Two days after vaccination with Oral polio vaccine and DTPa, the subject experienced Guillain Barre Syndrome. This case was assessed as medically serious by GSK. At the time of reporting the outcome of the events was unspecified. The author considered that internationally, there are advantages to using oral polio vaccine, but the stability of vaccine-derived oral polio vaccine viruses remained a concern and importation of such neurovirulent isolated to non endemic areas remained an important risk.
Patient stated after vaccination, he had a "foggy brain" and cannot think straight for the past day.  He claimed the vaccine gave him this state. Patient stated he typically intakes about 10 alcoholic drinks per day and only had 6 yesterday (12/29) but does not believe this has anything to do with his "foggy brain." I informed him this reaction is rare if it is from the vaccine but should only last up to three days. Fatigue can be a common side effect. I advised patient to decrease his alcoholic intake and if he still has "foggy brain" after 5 days or if it gets worse to see a provider. He requested a note for his employer, but I advised he would need that from a provider that can confirm his cognitive state.
pain in the injection site; fever of 37.7 °C; pain in his neck; This is a spontaneous report from contactable consumer. This consumer reported for his children (patient).  A 12-year-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/Lot number was not reported) via an unspecified route of administration on 08Jul2021 (at the age of vaccination 12-year-old) as dose number unknown, single for covid-19 immunization.The patient's medical history and concomitant medications were not reported. It was reported that yesterday reporter and children (patient) both were vaccinated with the Pfizer Covid-19 vaccine around noon. On 08Jul2021 at night, one of the children had pain in his neck, the other malaise and reporter gave them paracetamol. On 09Jul2021(Today), they have a fever of 37.7 degree C and pain in the injection site. The patient underwent lab tests which included body temperature: 37.7 centigrade on 09Jul2021.The outcome of all events was unknown.  Information about lot/Batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021875528 same reporter/ drug, different AE/patient
excessive crying p/3 hr of shots for >3 hr; fever up to 101.4;
This spontaneous report as received from a medical assistant refers to a 62 year old female patient with allergic to morphine and PERCOCET and no pertinent medical history. On 15-JUN-2013 the patient was vaccinated subcutaneously with a 0.65 ml ZOSTAVAX (lot# J0022692, EXP date 30-APR-2014) in the left arm. There was no concomitant therapy. On 16-JUN-2013 the patient's left arm, at site of injection, became red, warm to the touch and sore. Patient called the physician's office today, on 17-JUN-2013, to report the adverse event. She did not come into the office. Patient did not seek medical attention. There was no treatment given to patient. At time of report, the outcome of event was reported as not recovered. Additional information has been requested.
wake up every night and have difficulty to fall back to sleep again.; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown), via an unspecified route of administration on 10Mar2021 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 15Mar2021, the patient woke up every night and had difficulty falling back to sleep again. The patient did not receive any treatment for the reported event. The clinical outcome of the event of wake up every night and have difficulty to fall back to sleep again was not resolved at the time of this report. Information on lot/batch number has been requested. No further information is expected.
Patient given MENVEO. Rash appeared on trunk, arms and legs within 30 minutes. No shortness of breath or angioedema. Given 50 mg BENADRYL and taken to urgent. Physician stated no further treatment. Advised to consult with allergist ASAP.
Sudden severe weakness, falls, severe delirium and confusion starting the night of the vaccine (2nd dose).  Occurred over the course of a month of improvement and relapse until complete breakdown and detachment from reality at which time was taken by ambulance to Hospital.  Spent 10 days there doctors ran multiple tests, made multiple medication changes and patient worsened, but was transferred to a Rehab where she started to improve after being put back on her original medications and beginning PT,  OT, and Speech Therapy.  Stayed there from Sep 10 through October 28th at which time she was discharged to home with ongoing in home nursing care PT and OT and is still receiving those services as of the date of this writing 12/30/21.  Delirium had completely gone away now, but is still physically impaired beyond what she had prior to the vaccine.  Also, has developed hypothyroidism since the vaccine and has been put on Levothyroxine to treat.  Also has developed urinary incontinence during her stay at Hospital and rehab and is currently being treated by Myrbetric.
Rash all over neck and shoulders. Under breast and armpits. Red and painful. Itchy. Treated with steroid shot and steroid given to take orally for 1 week